Is IgA nephropathy the same disease in different parts of the world?
- 20 August 2021
- journal article
- review article
- Published by Springer Nature in Seminars in Immunopathology
- Vol. 43 (5) , 707-715
Abstract
Since it was first described in 1968, immunoglobulin A nephropathy (IgAN) is understood to be the most common form of glomerulonephritis worldwide. The diagnosis of IgAN depends on the presence of dominant mesangial IgA1 deposition by renal biopsy. To date, a wide spectrum of clinical and pathologic features of IgAN have been observed, implying that IgAN might not be the same disease across the world. Here, we review the characteristics of IgAN from perspectives of epidemiology, clinical-pathological patterns, disease pathogenesis, and treatment response across different ethnic populations. Overall, IgAN is most prevalent in Asians, followed by Caucasians, and relatively rare in Africans. More severe clinical presentation and higher risk of disease progression have been reported in Asians than Europeans. Moreover, active lesions, such as endocapillary hypercellularity and crescents, are more commonly reported in Asians than Europeans. Response to corticosteroid/immunosuppression therapy is variably reported, with greater apparent efficacy reported in Asian than European studies. Although a multi-hit hypothesis has been suggested for IgAN, the relative importance of each “hit” may vary in different ethnic populations and this variation underlies the differences in presentation of IgAN. In the future, a better understanding of pathogenic pathways operating in different ethnic populations may help provide better biomarkers of disease and more precise targeting of treatment strategies for IgAN.Keywords
Funding Information
- National Natural Science Foundation of China (82070733)
This publication has 82 references indexed in Scilit:
- Validation of the Oxford classification of IgA nephropathy for pediatric patients from ChinaBMC Nephrology, 2012
- Validation Study of Oxford Classification of IgA NephropathyClinical Journal of the American Society of Nephrology, 2011
- The Use of the Oxford Classification of IgA Nephropathy to Predict Renal SurvivalClinical Journal of the American Society of Nephrology, 2011
- Pathologic Predictors of Renal Outcome and Therapeutic Efficacy in IgA NephropathyClinical Journal of the American Society of Nephrology, 2011
- Genome-wide association study identifies susceptibility loci for IgA nephropathyNature Genetics, 2011
- Galactose-Deficient IgA1 in African Americans with IgA NephropathyClinical Journal of the American Society of Nephrology, 2010
- HLA Has Strongest Association with IgA Nephropathy in Genome-Wide AnalysisJournal of the American Society of Nephrology, 2010
- Genetic studies of IgA nephropathy: past, present, and futurePediatric Nephrology, 2010
- Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneityJournal of Clinical Investigation, 2009
- Effect of Tonsillectomy Plus Steroid Pulse Therapy on Clinical Remission of IgA NephropathyClinical Journal of the American Society of Nephrology, 2008